Omarigliptin Improves Glycemic Control and Is Well Tolerated as Add-on Therapy to Oral Antihyperglycemic Agents in Japanese Patients with Type 2 Diabetes

被引：0
|
作者：
Gantz, Ira
Okamoto, Taro
Sato, Asako
Okuyama, Kotoba
Lai, Eseng
Engel, Samuel S.
机构：
来源：
DIABETES | 2015年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1231-P
引用
收藏
页码：A318 / A319
页数：2
相关论文
共 50 条
  • [21] Combination of liraglutide and sitagliptin therapy improves glycemic control in Japanese patients with type 2 diabetes mellitus
    Matsuhashi, Yuki
    Chikazawa, Shinji
    Otaka, Hideyuki
    Takahashi, Kazuhisa
    Kabma, Aya
    Matsumura, Koki
    Matsuki, Kota
    Sato, Eri
    Tanabe, Jutaro
    Yanagimachi, Miyuki
    Murakami, Hiroshi
    Daimon, Makoto
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S101 - S101
  • [22] Vildagliptin as add-on therapy to insulin improves glycemic control without increasing risk of hypoglycemia in Asian, predominantly Chinese, patients with type 2 diabetes mellitus
    Ning, Guang
    Wang, Weiqing
    Li, Ling
    Ma, Jianhua
    Lv, Xiaofeng
    Yang, Ming
    Wang, Wei
    Woloschak, Michael
    Lukashevich, Valentina
    Kothny, Wolfgang
    JOURNAL OF DIABETES, 2016, 8 (03) : 345 - 353
  • [23] Long-term treatment with empagliflozin as add-on to oral antidiabetes therapy in Japanese patients with type 2 diabetes mellitus
    Araki, E.
    Tanizawa, Y.
    Tanaka, Y.
    Taniguchi, A.
    Koiwai, K.
    Kim, G.
    Salsali, A.
    Woerle, H. J.
    Broedl, U. C.
    DIABETES OBESITY & METABOLISM, 2015, 17 (07): : 665 - 674
  • [24] Long-term treatment with imeglimin as add-on to oral antidiabetes therapy in Japanese patients with type 2 diabetes (Times 2)
    Kaku, K.
    Dubourg, J.
    Thang, C.
    Kaneko, T.
    Fouqueray, P.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S306 - S306
  • [25] Clinical outcomes of basal insulin and oral antidiabetic agents as an add-on to dual therapy in patients with type 2 diabetes mellitus
    Chih-Ning Cheng
    Chih-Yuan Wang
    Hung-Wei Lin
    Ting-Yu Chang
    Hsu-Ju Lin
    Chiahung Chou
    Fang-Ju Lin
    Scientific Reports, 10
  • [26] Clinical outcomes of basal insulin and oral antidiabetic agents as an add-on to dual therapy in patients with type 2 diabetes mellitus
    Cheng, Chih-Ning
    Wang, Chih-Yuan
    Lin, Hung-Wei
    Chang, Ting-Yu
    Lin, Hsu-Ju
    Chou, Chiahung
    Lin, Fang-Ju
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [27] Erratum to: Evaluation of add-on therapy of sitagliptin in Japanese patients with type 2 diabetes under insulin therapy
    Tomoko Nakagami
    Risa Ide
    Naoko Iwasaki
    Makiko Ogata
    Junko Oya
    Mari Osawa
    Nobue Tanaka
    Hiroko Takaike
    Asako Sato
    Junnosuke Miura
    Yasuko Uchigata
    Diabetology International, 2014, 5 (3) : 198 - 198
  • [28] Dapagliflozin as add-on therapy in Asian patients with type 2 diabetes inadequately controlled on insulin with or without oral antihyperglycemic drugs: A randomized controlled trial
    Yang, Wenying
    Ma, Jianhua
    Li, Yiming
    Li, Yanbing
    Zhou, Zhiguang
    Kim, Jae Hyeon
    Zhao, June
    Ptaszynska, Agata
    JOURNAL OF DIABETES, 2018, 10 (07) : 589 - 599
  • [29] Saxagliptin improves glycaemic control either as add-on therapy to metformin or as initial combination therapy with metformin in patients with type 2 diabetes
    Gurieva, I.
    Pfuetzner, A.
    Antsiferov, M.
    Allen, E.
    Ravichandran, S.
    Chen, R.
    EUROPEAN HEART JOURNAL, 2009, 30 : 226 - 227
  • [30] Saxagliptin improves glycaemic control either as add-on therapy to metformin or as initial combination therapy with metformin in patients with type 2 diabetes
    Pfuetzner, A.
    Gurieva, I
    Antsiferov, M.
    Allen, E.
    Ravichandran, S.
    Chen, R.
    SWISS MEDICAL WEEKLY, 2009, 139 (33-34) : 168S - 169S
12345